Latin American Contract Research Organization Market

Lower Cost of Conducting Clinical Trials will Drive Growth

USD 3,950

* Required Fields

USD 3,950

PAY BY INVOICE

Be the first to review this product

This research service presents an overview and analysis of the Latin American Contract Research Organization (CRO) market with a focus on Argentina, Brazil, and Mexico. It provides country revenue by phase, therapeutic type, and region. The study discusses key challenges and emerging market trends, while providing detailed information on support services such as central laboratory services. It also outlines market drivers and restraints, market engineering measurements, and research and development trends. The study covers the CRO industry’s complete life cycle from phase I trials to post-marketing surveillance, and also highlights emerging trends and their importance in current and future market scenarios.

Table of Contents

Executive Summary—Latin AmericaKey Findings—LATAMKey Findings—LATAM (continued)Key Findings—LATAM (continued)Key Findings—LATAM (continued)Key Findings—LATAM (continued)Key Findings—LATAM (continued)Market Size Estimation MethodologyScope and SegmentationKey Questions this Study will AnswerMarket Engineering Measurements—LATAMCEO’s PerspectiveKey Companies to Watch3 Big PredictionsMarket Overview—Latin AmericaMarket Perspective—LATAMCRO Market Landscape—LATAMCRO Market Attractiveness by Phase—LATAMPorter’s Five Forces Analysis for the LATAM CRO MarketCRO Product Development & CommercializationMarket Segmentation—By Stages of Clinical DevelopmentMarket Overview—ArgentinaKey Findings—ArgentinaPharmaceutical Market Overview—ArgentinaPharmaceutical Market Overview—Argentina (continued)Pharmaceutical Market Overview—Argentina (continued)Pharmaceutical Market Overview—Argentina (continued)Market Perspective—ArgentinaCRO Market Landscape—ArgentinaClinical Trials Market Overview—ArgentinaClinical Trials Market Overview—ArgentinaClinical Trials Market Revenue Forecast—ArgentinaClinical Trials Market Revenue Forecast Discussion—ArgentinaProfiles of Clinical Trials—ArgentinaProfiles of Clinical Trials—Argentina (continued)Clinical Trials Scenario—ArgentinaClinical Trials Scenario—Argentina (continued)Clinical Trials Sponsorship—ArgentinaDrivers and Restraints—ArgentinaDrivers and Restraints—ArgentinaDrivers Explained—ArgentinaDrivers Explained—Argentina (continued)Restraints Explained—ArgentinaRestraints Explained—Argentina (continued)Forecasts and Trends: CRO Market—ArgentinaForecast AssumptionsMarket Engineering Measurements—ArgentinaArgentina CRO Market—Revenue ForecastArgentina CRO Market—Revenue Forecast DiscussionCRO Market Snapshot—ArgentinaArgentina CRO Market—Phase I & Phase IIArgentina CRO Market—Phase III & Late PhaseArgentina CRO Market—Data ManagementArgentina CRO Market—Data Management (continued)Argentina CRO Market—BiostatisticsArgentina CRO Market—Biostatistics(continued)Argentina CRO Market—Central Laboratory ServicesArgentina CRO Market—Central Laboratory Services (continued)Argentina CRO Market—Health Economics and Outcomes Research (HEOR)Argentina CRO Market—Health Economics and Outcomes Research (continued)Argentina CRO Market—PharmacovigilanceArgentina CRO Market—Pharmacovigilance (continued)Argentina CRO Market—Postmarketing SurveillanceArgentina CRO Market—Postmarketing Surveillance (continued)Argentina CRO Market Segmentation—By Stages of Clinical DevelopmentKey Market Trends—ArgentinaRegulatory Environment—ArgentinaClinical Research Regulatory Overview—ArgentinaClinical Research Regulatory Process—ArgentinaClinical Research Regulatory Process—Argentina (continued)Clinical Research Regulatory Process—Argentina (continued)Competitive Environment—ArgentinaCompetitive Analysis—ArgentinaMarket Share Analysis—ArgentinaCompetitive Structure—ArgentinaCompetitive Analysis—Selected Key Market ParticipantsCompetitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Market Overview—BrazilKey Findings—BrazilPharmaceutical Market Overview—BrazilPharmaceutical Market Overview—Brazil (continued)Pharmaceutical Market Overview—Brazil (continued)Pharmaceutical Market Overview—Brazil (continued)Pharmaceutical Market Overview—Brazil (continued)Pharmaceutical Market Overview—Brazil (continued)Market Perspective—BrazilCRO Market Landscape—BrazilClinical Trials Market Overview—BrazilClinical Trials Market Overview—BrazilClinical Trials Market Revenue Forecast—BrazilClinical Trials Market Revenue Forecast Discussion—BrazilProfiles of Clinical Trials—BrazilProfiles of Clinical Trials—Brazil (continued)Clinical Trials Scenario—BrazilClinical Trials Scenario—Brazil (continued)Clinical Trials Sponsorship—BrazilDrivers and Restraints—BrazilDrivers and Restraints—BrazilDrivers Explained—BrazilDrivers Explained—Brazil (continued)Drivers Explained—Brazil (continued)Restraints Explained—BrazilRestraints Explained—Brazil (continued)Forecasts and Trends: CRO Market—BrazilForecast AssumptionsMarket Engineering Measurements—BrazilBrazil CRO Market—Revenue ForecastBrazil CRO Market—Revenue Forecast DiscussionCRO Market Snapshot—BrazilBrazil CRO Market—Phase I & Phase IIBrazil CRO Market—Phase III & Late PhaseBrazil CRO Market—Data ManagementBrazil CRO Market—Data Management (continued)Brazil CRO Market—BiostatisticsBrazil CRO Market—Biostatistics (continued)Brazil CRO Market—Central Laboratory ServicesBrazil CRO Market—Central Laboratory Services (continued)Brazil CRO Market—Health Economics and Outcomes Research (HEOR)Brazil CRO Market—Health Economics and Outcomes Research (continued)Brazil CRO Market—PharmacovigilanceBrazil CRO Market—Pharmacovigilance (continued)Brazil CRO Market—Postmarketing SurveillanceBrazil CRO Market—Postmarketing Surveillance (continued)Brazil CRO Market Segmentation—By Stages of Clinical DevelopmentKey Market Trends—BrazilRegulatory Environment—BrazilClinical Research Regulatory Overview—BrazilClinical Research Regulatory Overview—Brazil (continued)Clinical Research Regulatory Overview—Brazil (continued)Clinical Research Regulatory Process—BrazilCompetitive Environment—BrazilCompetitive Analysis—BrazilMarket Share Analysis—BrazilCompetitive Structure—BrazilCompetitive Analysis—Selected Key Market ParticipantsCompetitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Market Overview—MexicoKey Findings—MexicoPharmaceutical Market Overview—MexicoPharmaceutical Market Overview—Mexico (continued)Pharmaceutical Market Overview—Mexico (continued)Pharmaceutical Market Overview—Mexico (continued)Pharmaceutical Market Overview—Mexico (continued)Market Perspective—MexicoCRO Market Landscape—MexicoClinical Trials Market Overview—MexicoClinical Trials Market Overview—MexicoClinical Trials Market Revenue Forecast—MexicoClinical Trials Market Revenue Forecast Discussion—MexicoProfiles of Clinical Trials—MexicoProfiles of Clinical Trials—Mexico (continued)Clinical Trials Scenario—MexicoClinical Trials Scenario—Mexico (continued)Clinical Trials Sponsorship—MexicoDrivers and Restraints—MexicoDrivers and Restraints—MexicoDrivers Explained—MexicoDrivers Explained—Mexico (continued)Restraints Explained—MexicoRestraints Explained—Mexico (continued)Forecasts and Trends: CRO Market—MexicoForecast AssumptionsMarket Engineering Measurements—MexicoMexico CRO Market—Revenue ForecastMexico CRO Market—Revenue Forecast DiscussionCRO Market Snapshot—MexicoMexico CRO Market—Phase I & Phase IIMexico CRO Market—Phase IIII & Late PhaseMexico CRO Market—Data ManagementMexico CRO Market—Data Management (continued)Mexico CRO Market—BiostatisticsMexico CRO Market—Biostatistics (continued)Mexico CRO Market—Central Laboratory ServicesMexico CRO Market—Central Laboratory Services (continued)Mexico CRO Market—Health Economics and Outcomes Research (HEOR)Mexico CRO Market—Health Economics and Outcomes Research (continued)Mexico CRO Market—PharmacovigilanceMexico CRO Market—Pharmacovigilance (continued)Mexico CRO Market—Postmarketing SurveillanceMexico CRO Market—Postmarketing Surveillance (continued)Mexico CRO Market Segmentation—By Stages of Clinical DevelopmentKey Market Trends—MexicoRegulatory Environment—MexicoClinical Research Regulatory Overview—MexicoClinical Research Regulatory Overview—Mexico (continued)Clinical Research Regulatory Overview—Mexico (continued)Clinical Research Regulatory Process—MexicoCompetitive Environment—MexicoCompetitive Analysis—MexicoMarket Share Analysis—MexicoCompetitive Structure—MexicoCompetitive Analysis—Selected Key Market ParticipantsCompetitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)The Last Word3 Big PredictionsThe Last Word—DiscussionLegal DisclaimerAppendixList of ExhibitsList of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)Market Engineering MethodologyLearn More—Next Steps

Infographic





Related Research

Release Date : 09-Nov-17

Region : Latin America

Release Date : 06-Nov-17

Region : Latin America

Release Date : 31-Oct-17

Region : Latin America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.